Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901

The development of efficient immunotherapies requires strong rationalization. We have recently implemented a large analysis of biomarkers in two studies involving the multi-peptide vaccine IMA901 and advanced renal cell cancer patients. Our findings demonstrate that the breadth of immune responses w...

Descripción completa

Detalles Bibliográficos
Autores principales: Walter, Steffen, Weinschenk, Toni, Reinhardt, Carsten, Singh-Jasuja, Harpreet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583911/
https://www.ncbi.nlm.nih.gov/pubmed/23482454
http://dx.doi.org/10.4161/onci.22246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583911/
https://www.ncbi.nlm.nih.gov/pubmed/23482454
http://dx.doi.org/10.4161/onci.22246

Ejemplares similares